Emergent BioSolutions

World News

Bavarian Nordic Shares Surge Amid WHO’s Mpox Emergency Declaration

Shares of Bavarian Nordic surged on Friday following the World Health Organization’s (WHO) declaration of a public health emergency over a growing mpox outbreak in Africa. The Danish company, which produces the only globally approved mpox vaccine under the brand names Jynneos, Imvamune, and Imvanex, saw its stock jump more than 14% during early trading in Copenhagen. Although the gains…